Market Place
Sourcing Support
Corium, Lotus Pharmaceutical Partner on Alzheimer`s Drug Adlarity
10 Aug 2023 //
CONTRACT PHARMA
Lotus` Generic Lenalidomide Receives Approval in the U.S.
06 Mar 2023 //
FDA
Lotus` Generic Nintedanib Esylate Receives Approval in the U.S.
12 Jan 2023 //
FDA
Lotus` Generic Nintedanib Receives Approval in the U.S.
12 Jan 2023 //
FDA
Lotus acquires Alimta in Taiwan from Eli Lilly for $62 M
15 Dec 2022 //
BIOSPECTRUMASIA
Lotus Reports Its Best Quarter Ever With The Biggest Launch In Its History
11 Nov 2022 //
PRNEWSWIRE
Innobic, Aztiq acquire Lotus Pharmaceutical, Adalvo for $475m
30 May 2022 //
NATIONTHAILAND
Glenmark, Lotus partner for Ryaltris in key South East Asian markets
21 Jan 2022 //
EXPRESS PHARMA
Indian firm Glenmark brings nasal spray in Singapore, Hong Kong and Vietnam
20 Jan 2022 //
BIOSPECTRUMASIA
PharmaMar Partners with Lotus Pharmaceutical for lurbinectedin in Taiwan
11 Nov 2021 //
FIRSTWORDPHARMA
PTT, Lotus Pharma explore opportunities in South East Asia pharma markets
20 Apr 2021 //
BIOSPECTRUMASIA
Revlimid® (Lenalidomide): Celgene Corporation v. Lotus Pharmaceutical Co., Alvogen Group, Inc.
16 Jul 2018 //
PATENT LITIGATION
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.